BDTX
NASDAQ
$1.81
Black Diamond Therapeutics Inc (BDTX)
Black Diamond Therapeutics, Inc., a biotechnology company, discovers and develops small molecule tumor agnostic therapies. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9.86 (+444.75%)
Market Cap
$104M
Profit Margin
80.8%
Free Cash Flow Yield
-32.81%
Beta (5Y)
1.70
Price Chart
Valuation
Market Cap$104M
Forward P/E8.33
P/S2.11
P/B1.02
Profitability
Gross Profit (TTM)$70M
EBITDA-$53M
Profit Margin80.8%
Operating Margin77.9%
EPS-$0.76
Financial Health
Free Cash Flow Yield-32.81%
Growth & Risk
EPS 5Y CAGR-20.40%
FCF 5Y CAGR-12.27%
Beta (5Y)1.70
Sharpe Ratio-0.27